Encompass Health Corporation — Cyborg Score 8/10

Strong
Healthcare - Inpatient Rehabilitation Facilities

Strategic Profile

Encompass Health continues to strengthen its network through de novo hospitals and additional bed capacity across existing facilities, with capacity expansion remaining a key growth driver. The company maintains a strong trailing 12-month return on invested capital (ROIC) of 10.1%, well above the industry average of 6.7%, reflecting disciplined capital deployment and efficient operations.

Cyborg Score Rationale

In Q1 2026, total discharges increased 4.3% year-over-year while adjusted EBITDA increased 11.2%, with adjusted EPS rising 16.8%. The company expects adjusted free cash flow between $760 million and $875 million in 2026, positioning it well to fund growth projects, dividends and share repurchases. The main headwind is elevated debt levels relative to peers.

Top Insights

  • For 2026, management plans to open eight de novos, adding nearly 389 beds, along with 150-200 additional beds at existing hospitals
  • EHC has successfully reduced RN turnover to 17.8%, the lowest since 2012, contributing to a 9.4% decline in premium labor spend compared to Q1 2025
  • 2026 guidance assumes net operating revenue of $6.375 billion to $6.470 billion, adjusted EBITDA of $1.35 billion to $1.38 billion, and adjusted EPS of $5.89 to $6.11
  • Expanded use of advanced analytics partnerships, notably with Palantir, was highlighted as a strategic investment supporting operational and clinical decision-making, documentation efficiency, and real estate development

Named Competitors

  • Kindred Realty Trust — Post-acute care operator with inpatient rehabilitation hospitals
  • HealthSouth Facilities — Historical inpatient rehabilitation facilities before consolidation
  • Skilled Nursing Facilities — Alternative post-acute care providers

Recent Developments

  • (May 2026) Announced plans to build a 50-bed inpatient rehabilitation hospital in Post Falls, Idaho
  • (May 2026) Opened Encompass Health Rehabilitation Hospital of Concordville in Pennsylvania
  • (April 2026) Raised full-year 2026 guidance following strong Q1 earnings with 9% revenue growth and 11.2% adjusted EBITDA growth

Open the full interactive Encompass Health Corporation report

Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.

Open report →